Published in PLoS One on January 31, 2011
Prevalence of human papillomavirus in adolescent girls before reported sexual debut. J Infect Dis (2014) 1.47
Trichomonas vaginalis: a review of epidemiologic, clinical and treatment issues. BMC Infect Dis (2015) 0.96
The association between Trichomonas infection and incarceration in HIV-seropositive and at-risk HIV-seronegative women. Sex Transm Dis (2011) 0.89
Epidemiology and treatment of trichomoniasis. Curr Infect Dis Rep (2015) 0.82
Trichomoniasis - are we giving the deserved attention to the most common non-viral sexually transmitted disease worldwide? Microb Cell (2016) 0.75
Trichomoniasis: Is it always sexually transmitted? Indian J Sex Transm Dis (2015) 0.75
Prevalence and risk factors associated with sexually transmitted infections (STIs) among women of reproductive age in Swaziland. Infect Agent Cancer (2017) 0.75
Prevalence of Trichomonas vaginalis infection and protozoan load in South African women: a cross-sectional study. BMJ Open (2017) 0.75
Non-ulcerative sexually transmitted diseases as risk factors for HIV-1 transmission in women: results from a cohort study. AIDS (1993) 10.84
Trichomonas vaginalis associated with low birth weight and preterm delivery. The Vaginal Infections and Prematurity Study Group. Sex Transm Dis (1997) 6.64
Reduction of concentration of HIV-1 in semen after treatment of urethritis: implications for prevention of sexual transmission of HIV-1. AIDSCAP Malawi Research Group. Lancet (1997) 6.34
Trichomonas vaginalis: reevaluation of its clinical presentation and laboratory diagnosis. J Infect Dis (1980) 5.83
A systematic review of the epidemiologic interactions between classic sexually transmitted diseases and HIV: how much really is known? Sex Transm Dis (2001) 4.73
Global prevalence and incidence estimates of selected curable STDs. Sex Transm Infect (1998) 4.39
Infection with Trichomonas vaginalis increases the risk of HIV-1 acquisition. J Infect Dis (2007) 4.12
Trichomonas vaginalis infection and human immunodeficiency virus acquisition in African women. J Infect Dis (2008) 3.98
Multicentre study on factors determining differences in rate of spread of HIV in sub-Saharan Africa: methods and prevalence of HIV infection. AIDS (2001) 3.53
The effect of treatment of vaginal infections on shedding of human immunodeficiency virus type 1. J Infect Dis (2001) 2.79
Trichomonas vaginalis: repeated DNA target for highly sensitive and specific polymerase chain reaction diagnosis. Cell Mol Biol (Noisy-le-grand) (1994) 2.39
Trichomonas vaginalis treatment reduces vaginal HIV-1 shedding. Sex Transm Dis (2009) 2.30
Epidemiological studies on human trichomoniasis. Am J Trop Med Hyg (1959) 1.71
The epidemiology of trichomoniasis in women in four African cities. AIDS (2001) 1.55
Colorimetric one-tube nested PCR for detection of Trichomonas vaginalis in vaginal discharge. J Clin Microbiol (1997) 1.46
Comparison of culture and different PCR assays for detection of Trichomonas vaginalis in self collected vaginal swab specimens. Sex Transm Infect (2003) 1.45
Atypical pelvic inflammatory disease: can we identify clinical predictors? Am J Obstet Gynecol (1993) 1.24
Trichomonas vaginalis transmission in a family. Genitourin Med (1995) 1.02
Epidemiology of trichomonas vaginalis (TV) in rural adolescent and juvenile children. J Trop Pediatr (1991) 1.01
Trichomonas vaginalis is highly prevalent in adolescent girls, pregnant women, and commercial sex workers in Ndola, Zambia. Sex Transm Dis (2010) 1.01
Lack of evidence for the involvement of rectal and oral trichomonads in the aetiology of vaginal trichomoniasis in Ghana. Sex Transm Infect (2006) 0.85
[Survival ability of Trichomonas vaginalis in mineral baths]. Gesundheitswesen (1995) 0.81
Iatrogenic transmission of Trichomonas vaginalis by a traditional healer. Sex Transm Infect (2010) 0.79
[Critical study of the possibilities of extra-venereal contamination in urogenital trichomoniasis. On contamination by linen and underclothing]. Rev Fr Gynecol Obstet (1961) 0.78
Transmission of HIV-1 infection in sub-Saharan Africa and effect of elimination of unsafe injections. Lancet (2004) 4.13
Syphilis in pregnancy in Tanzania. I. Impact of maternal syphilis on outcome of pregnancy. J Infect Dis (2002) 3.22
Biomedical interventions to prevent HIV infection: evidence, challenges, and way forward. Lancet (2008) 2.75
Performance of commercially available enzyme immunoassays for detection of antibodies against herpes simplex virus type 2 in African populations. J Clin Microbiol (2004) 2.55
Male circumcision for HIV prevention in sub-Saharan Africa: who, what and when? AIDS (2008) 2.54
HIV prevalence and associated risk factors among individuals aged 13-34 years in Rural Western Kenya. PLoS One (2009) 2.54
Syphilis in pregnancy in Tanzania. II. The effectiveness of antenatal syphilis screening and single-dose benzathine penicillin treatment for the prevention of adverse pregnancy outcomes. J Infect Dis (2002) 2.39
The vaginal microbiota and susceptibility to HIV. AIDS (2014) 2.24
Proportion of new HIV infections attributable to herpes simplex 2 increases over time: simulations of the changing role of sexually transmitted infections in sub-Saharan African HIV epidemics. Sex Transm Infect (2007) 1.89
HIV type 1 subtype distribution, multiple infections, sexual networks, and partnership histories in female sex workers in Kampala, Uganda. AIDS Res Hum Retroviruses (2011) 1.63
Understanding the differences between contrasting HIV epidemics in east and west Africa: results from a simulation model of the Four Cities Study. Sex Transm Infect (2007) 1.60
HIV risk in relation to marriage in areas with high prevalence of HIV infection. J Acquir Immune Defic Syndr (2003) 1.57
Treating curable sexually transmitted infections to prevent HIV in Africa: still an effective control strategy? J Acquir Immune Defic Syndr (2008) 1.48
Does increased general schooling protect against HIV infection? A study in four African cities. Trop Med Int Health (2004) 1.20
Evaluation of a U.S. evidence-based parenting intervention in rural Western Kenya: from parents matter! To families matter! AIDS Educ Prev (2010) 1.19
Double ethical review of North-South collaborative clinical research: hidden paternalism or real partnership? Trop Med Int Health (2011) 1.16
Quantification of bacterial species of the vaginal microbiome in different groups of women, using nucleic acid amplification tests. BMC Microbiol (2012) 1.12
Quality of antenatal and delivery care before and after the implementation of a prevention of mother-to-child HIV transmission programme in Côte d'Ivoire. Trop Med Int Health (2008) 1.09
Population-level effect of potential HSV2 prophylactic vaccines on HIV incidence in sub-Saharan Africa. Vaccine (2008) 1.08
Searching for lower female genital tract soluble and cellular biomarkers: defining levels and predictors in a cohort of healthy Caucasian women. PLoS One (2012) 1.08
Prevalence and correlates of Mycoplasma genitalium infection among female sex workers in Kampala, Uganda. J Infect Dis (2011) 1.06
Gender inequity in the lives of women involved in sex work in Kampala, Uganda. J Int AIDS Soc (2012) 1.06
Obtaining valid laboratory data in clinical trials conducted in resource diverse settings: lessons learned from a microbicide phase III clinical trial. PLoS One (2010) 1.05
HIV and other sexually transmitted infections among female sex workers in Kinshasa, Democratic Republic of Congo, in 2002. Sex Transm Dis (2007) 1.01
Trichomonas vaginalis is highly prevalent in adolescent girls, pregnant women, and commercial sex workers in Ndola, Zambia. Sex Transm Dis (2010) 1.01
HIV transmission in serodiscordant heterosexual couples. BMJ (2010) 0.99
Management of pulmonary tuberculosis patients in an urban setting in Zambia: a patient's perspective. BMC Public Health (2010) 0.96
HIV and STI prevalence among female sex workers in Côte d'Ivoire: why targeted prevention programs should be continued and strengthened. PLoS One (2012) 0.95
Sustainability of programs to reach high risk and marginalized populations living with HIV in resource limited settings: implications for HIV treatment and prevention. BMC Public Health (2011) 0.94
Identification of amino acid substitutions associated with neutralization phenotype in the human immunodeficiency virus type-1 subtype C gp120. Virology (2010) 0.94
The weight of evidence: a method for assessing the strength of evidence on the effectiveness of HIV prevention interventions among young people. World Health Organ Tech Rep Ser (2006) 0.94
Vaginal practices among women at high risk of HIV infection in Uganda and Tanzania: recorded behaviour from a daily pictorial diary. PLoS One (2013) 0.92
Condom use among female sex workers in Uganda. AIDS Care (2012) 0.92
HIV sexual transmission and microbicides. Rev Med Virol (2011) 0.91
Integration of comprehensive abortion-care services in a Maternal and Child Health clinic in Cambodia. Trop Med Int Health (2008) 0.89
Natural history of Mycoplasma genitalium infection in a cohort of female sex workers in Kampala, Uganda. Sex Transm Dis (2013) 0.88
Vaginal microbicides can interfere with nucleic acid amplification tests used for the diagnosis of Chlamydia trachomatis and Neisseria gonorrhoeae infection. Diagn Microbiol Infect Dis (2006) 0.87
Assessment of HIV-related risky behaviour: a comparative study of face-to-face interviews and polling booth surveys in the general population of Cotonou, Benin. Sex Transm Infect (2013) 0.87
'It is like a tomato stall where someone can pick what he likes': structure and practices of female sex work in Kampala, Uganda. BMC Public Health (2013) 0.86
Prophylaxis of opportunistic infections in HIV-infected adults in sub-Saharan Africa: opportunities and obstacles. AIDS (2002) 0.86
The interface between health systems and vertical programmes in Francophone Africa: the managers' perceptions. Trop Med Int Health (2011) 0.86
Operational assessment of access to ART in rural Africa: the example of Kisantu in Democratic Republic of the Congo. AIDS Care (2011) 0.85
High prevalent and incident HIV-1 and herpes simplex virus 2 infection among male migrant and non-migrant sugar farm workers in Zambia. Sex Transm Infect (2011) 0.84
Vaginal practices diary: development of a pictorial data collection tool for sensitive behavioral data. Sex Transm Dis (2012) 0.84
Risk factors for HCV acquisition among HIV-positive MSM in Belgium. J Acquir Immune Defic Syndr (2015) 0.83
A dose-ranging phase I study of dextrin sulphate, a vaginal microbicide, in HIV-negative and HIV-positive female volunteers. Sex Transm Dis (2005) 0.82
Transmitted antiretroviral drug resistance among drug-naive female sex workers with recent infection in Kampala, Uganda. Clin Infect Dis (2012) 0.81
Clinical characteristics associated with Mycoplasma genitalium infection among women at high risk of HIV and other STI in Uganda. Sex Transm Dis (2012) 0.81
Decline in HIV prevalence among young men in the general population of Cotonou, Benin, 1998-2008. PLoS One (2012) 0.80
HIV prevention--where now? Background and introduction. AIDS (2010) 0.80
Safety trial of the vaginal microbicide cellulose sulfate gel in HIV-positive men. Sex Transm Dis (2007) 0.80
Control of viral replication after cessation of HAART. AIDS Res Ther (2011) 0.79
What is the significance of posttreatment control of HIV infection vis-à-vis functional cure? AIDS (2014) 0.78
Attempting to explain heterogeneous HIV epidemics in sub-Saharan Africa: potential role of historical changes in risk behaviour and male circumcision. Sex Transm Infect (2011) 0.77
Microbicides a long and bumpy road to success? AIDS Rev (2007) 0.76
Hormonal contraception and HIV acquisition - what is the evidence? What are the policy and operational implications? Eur J Contracept Reprod Health Care (2013) 0.76
Association of Sexual Debut in Adolescents With Microbiota and Inflammatory Markers. Obstet Gynecol (2016) 0.75
Penile application of dextrin sulphate gel (Emmelle). Contraception (2002) 0.75
Business and AIDS in South Africa. AIDS (2007) 0.75
Retention and risk factors for loss to follow-up of female and male sex workers on antiretroviral treatment in Ivory Coast: a retrospective cohort analysis. J Acquir Immune Defic Syndr (2015) 0.75